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Objective: Providencia stuartii is an opportunistic pathogen typically associated with urinary 
infections, and is intrinsically resistance to a wide range of antibiotics. The main aim of this 
study was to characterize five carbapenemase (CA) NDM-1-producing P. stuartii isolates 
obtained during an outbreak detected in a Hospital. 
Methods: MICs were obtained by the reference microdilution broth method, according to 
EUCAST guidelines. PCR amplification and DNA sequencing were applied to identify the 
presence of CA genes from class A, B and D. Direct transfer of the CA resistance phenotype 
was attempted by mating-out assays. Genetic relatedness was examined by PFGE. One 
isolate, INSRA21868, recovered from the urine of an 88-year-old male patient admitted to the 
intensive care unit, was selected for genetic characterization using whole-genome sequencing 
(WGS), performed using 150 bp paired-end reads on a MiSeq (Illumina). A set of bioinformatic 
web tools were used to estimate the presence of pathogenicity determinants, antibiotic 
resistance (AR) genes, and clinically relevant mobile genetic elements. 
Results: All isolates, genetically indistinguishable by PFGE, presented multidrug-resistance 
with non-susceptibility to all carbapenems tested. Transconjugants had AR profiles similar to 
those of their parental clinical isolates. All NDM-1 determinants tested were found to be carried 
on conjugative plasmids. In silico AR analyses using ResFinder-v2.1 revealed genes conferring 
resistance to β-lactams [blaNDM-1, blaCMY-4 and ΔblaDHA-1), aminoglycosides (aac(2’)-Ia, armA), 
tetracycline (tetB), macrolides (mphE and msrE), chloramphenicol (catB3), and sulfonamides 
(sul1). PlasmidFinder-v1.2 analyses revealed the presence of an IncA/C2, which has been 
associated with wide dissemination of blaNDM-1. In the 3’ region, the blaNDM-1 gene was adjacent 
to a bleomycin resistance-encoding gene (bleMBL), followed by a trpF and part of the blaDHA-1-
ampR region. The ISAba125 element upstream of blaNDM-1 was interrupted by an IS26 element. 
Conclusion: This study emphasizes the elements involved in dissemination of nosocomial 
infections and the potential of WGS in epidemiological investigations in the prevention of CA 
dissemination among hospitals as well as to other bacterial genera. 
